Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Sukumar, Sakamuri"'
Autor:
Feng Tian, Yi Gu, Sulan Yao, Shiao-Yan Fang, Wayne Yu, Ianina Lopez, Kristine Storey, Robin Marsden, Jessica Kirtley, Sandra Lyn Biroc, Wisam Barkho, Snezana Milutinovic, Amha Gebre Hewet, Nick A. Knudsen, Sukumar Sakamuri, Lillian Skidmore
Amino acid sequence of the antibody used in ARX788. The complementarity determining regions (CDRs) are underlined, and the pAF is depicted as a "U".
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ba9be2ac4c8985e17126246813d6898
https://doi.org/10.1158/1535-7163.22521019
https://doi.org/10.1158/1535-7163.22521019
Autor:
Feng Tian, Yi Gu, Sulan Yao, Shiao-Yan Fang, Wayne Yu, Ianina Lopez, Kristine Storey, Robin Marsden, Jessica Kirtley, Sandra Lyn Biroc, Wisam Barkho, Snezana Milutinovic, Amha Gebre Hewet, Nick A. Knudsen, Sukumar Sakamuri, Lillian Skidmore
First-generation antibody–drug conjugates (ADC) are heterogeneous mixtures that have shown clinical benefit, but generally exhibited safety issues and a narrow therapeutic window due, in part, to off-target toxicity caused by ADC instability. ARX78
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cde81fcd8199a2863a821a2439e8526
https://doi.org/10.1158/1535-7163.c.6542869
https://doi.org/10.1158/1535-7163.c.6542869
Autor:
Curt Bradshaw, Sukumar Sakamuri, Bin Liu, Laxman Eltepu, Ryan Preston, Dingguo Liu, Lisa Jo Reboton
Publikováno v:
ChemBioChem. 21:1298-1303
Since the recognition of oligonucleotides as a therapeutic modality, significant work has been devoted to improving therapeutic properties, including nuclease stability. Phosphorothioate (PS) modifications of phosphodiesters are one of the most explo
Autor:
Mark P. Foster, Curt W. Bradshaw, Giuseppe Dello Iacono, Laxman Eltepu, Bryan R. Meade, Son Lam, Tom Leedom, Sukumar Sakamuri, Bin Liu, Ayman Kabakibi, Dingguo Liu, Lena Luukkonen
Publikováno v:
ChemBioChem. 21:1304-1308
Oligonucleotides are important therapeutic approaches, as evidenced by recent clinical successes with antisense oligonucleotides (ASOs) and double-stranded short interfering RNAs (siRNAs). Phosphorothioate (PS) modifications are a standard feature in
Autor:
Sukumar, Sakamuri, Dingguo, Liu, Laxman, Eltepu, Bin, Liu, Lisa Jo, Reboton, Ryan, Preston, Curt W, Bradshaw
Publikováno v:
Chembiochem : a European journal of chemical biology. 21(9)
Since the recognition of oligonucleotides as a therapeutic modality, significant work has been devoted to improving therapeutic properties, including nuclease stability. Phosphorothioate (PS) modifications of phosphodiesters are one of the most explo
Autor:
Yingchun Lu, Vladimir Khazak, Katrin Illgen, Sanjay Menon, Yen-Fang Keng, Silke Schabbert, Lutz Weber, Sukumar Sakamuri, Quin-Zene Chen
Publikováno v:
Letters in Drug Design & Discovery. 3:44-48
Autor:
Vladimir Khazak, Katrin Illgen, Quin-Zene Chen, Sanjay Menon, Silke Schabbert, Yingchun Lu, Lutz Weber, Sukumar Sakamuri, Yen-Fang Keng
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 14:3957-3962
A solution phase parallel synthesis approach was undertaken to rapidly explore the structure–activity relationship of an inhibitor of the Ras/Raf protein interaction identified from a small molecule compound library. Evaluation of the MAPK pathway
Autor:
Sukumar Sakamuri, Alan P. Kozikowski, Kenneth M. Johnson, Srihari R. Tella, Istvan J. Enyedy, Shaomeng Wang, Wahiduz A. Zaman, Tivadar Farkas, Judith L. Flippen-Anderson
Publikováno v:
Bioorganic & Medicinal Chemistry. 11:1123-1136
There is considerable interest in developing dopamine transporter (DAT) inhibitors as potential therapies for the treatment of cocaine abuse. We report herein our pharmacophore-based discovery and molecular modeling-assisted rational design of 2,3-di
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:513-517
Abnormal dopamine signaling in brain has been implicated in several conditions such as cocaine abuse, Parkinson's disease and depression. Potent and selective dopamine transporter inhibitors may be useful as pharmacological tools and therapeutic agen
Autor:
Peter M. Blumberg, Zhi Liang Wei, Pavel A. Petukhov, Alan P. Kozikowski, Clifford George, Sukumar Sakamuri, Nancy E. Lewin
Publikováno v:
Organic Letters. 4:2169-2172
[structures: see text] Both (2S,5R,6R)- and (2S,5R,6S)-6-hydroxy-8-(1-decynyl)benzolactam-V8 were designed and synthesized as PKC modulators. Biological assays reveal the (6R)-ligand to be 20-fold more potent than its (6S)-counterpart in binding to P